J Korean Surg Soc.
2000 Sep;59(3):291-297.
The Prognostic Significance of Transfusion in Periampullary Cancer Following Pancreatoduodenectomy
- Affiliations
-
- 1Department of Surgery, Seoul National University College of Medicine.
Abstract
-
PURPOSE: There are several reports that intraoperative transfusion may be a prognostic factor in
periampullary cancer, but it is not conclusive. The purpose of this study is to clarify the prognostic
significance of a transfusion following a pancreatoduodenectomy for periampullary cancers. METHODS:
We analyzed 357 periampullary cancers from 1985 to 1997 (ampullary cancer: 130 cases; distal bile
duct cancer: 141 cases; and pancreatic head cancer: 86 cases). Analytic variables for possible prognostic
factors were various clinicopathologic factors combined with the presence of the perioperative transfusion.
RESULTS
Of the overall 357 patients, 215 (60%) have received an intraoperative transfusion. The 5-year
survival rate of the 130 ampullary cancer patients was 59%, and 76 cases (58%) underwent an intra
operative transfusion. The 5-year survival rate of patients without intraoperative transfusion was 79%
whereas that of patients with a transfusion was 47% (p=0.029). Following multivariate analysis, an
intraoperative transfusion was an independent prognostic factor in ampullary cancer (relative risk: 2.174).
In common bile duct cancer, the overall 5-year survival rate was 33%, and the 5-year survival rates
of patients with (N=87) or without (N=54) a transfusion were 25% and 38% respectively, which showed
a marginal statistical significance (p=0.0717). In pancreatic head cancer, the overall 5-year survival rate
was 16% and there was no survival difference between transfused (N=52) and untransfused (N=34)
patients. CONCLUSION: In the present study, intraoperative transfusion was an independent significant
prognostic factor in ampullary cancer. Careful dissection to minimize intraoperative bleeding is mandatory
in pancreatoduodenectomy for ampullary cancer.